SearchSearch results for: “”

On 27 July 2015, Teva Pharmaceutical Industries announced that it has withdrawn its previously announced hostile bid to acquire Mylan N.V. Stibbe represented Mylan in this successful takeover defence and advised Mylan on both litigation and EU competition

Stibbe advises a company in the chemical industry on a regulation case about safety standards.

Advising a transport organisation on the implementation of new regulation standards.

Advising a financial organisation how to avoid the publication of a sanction imposed by the regulator.

Advising an international fast moving consumer goods company on IT and privacy related matters, such as the use of cloud computing and the transfer of personal data outside of the European Economic Area.

Advising Amsterdam RAI, the largest Dutch congress and convention center, on e-commerce and privacy related matters.

Providing legal assistance to several companies with regard to investigations of the Social Affairs and Employment Inspectorate (SAE, in Dutch: Inspectie Sociale Zaken en Werkgelegenheid) and imposed fines under the Foreign Nationals (Employment) Act. 

Stibbe advised Akzo Nobel in an action before the General Court to prevent the European Commission from publishing information originating from leniency documents.

Stibbe advised Credit Suisse on the imposement of a fine by the European Commission for participating in a cartel involving interest rate products denominated in Swiss francs.

Stibbe advises Tornier N.V. on its merger with Wright Medical Group, Inc. in an all stock transaction with a combined equity value of approximately $3.3 billion.

Stibbe advises Mylan Inc., the pharmaceuticals company listed on the NASDAQ with a market cap of approximately $19 billion, on the inversion acquisition of Abbott’s non-U.S. developed markets specialty and branded generics business.

Stibbe assisted a leading pharmaceutical company in identifying the most cost-effective way to obtain in Belgium an improved pricing and reimbursement for new fixed-dose combination products composed of off-patent ingredients.

Stibbe assisted a warehousing company in the port of Antwerp in the competition law investigation, provisional measures, and appeal proceedings regarding alleged abuse of a dominant position for the load out of certified LIFFE coffee in the port.

Advising Canon in connection with their dispute with the State of the Netherlands on the procurement of framework contracts. Case won up to and including the Supreme Court.